IRIS PubliCatt

Macchia, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.525
NA - Nord America 5.608
AS - Asia 2.100
AF - Africa 74
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 11
Totale 14.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.529
DE - Germania 2.680
SE - Svezia 1.222
CN - Cina 878
SG - Singapore 623
IT - Italia 591
UA - Ucraina 544
IE - Irlanda 313
FR - Francia 256
GB - Regno Unito 235
ID - Indonesia 190
FI - Finlandia 185
IN - India 146
PL - Polonia 145
RU - Federazione Russa 114
TR - Turchia 101
CA - Canada 73
BE - Belgio 53
CI - Costa d'Avorio 53
CZ - Repubblica Ceca 38
JP - Giappone 36
NL - Olanda 33
BR - Brasile 30
IR - Iran 30
HK - Hong Kong 22
AT - Austria 19
LT - Lituania 18
VN - Vietnam 16
ES - Italia 12
EU - Europa 11
CH - Svizzera 9
EG - Egitto 9
RO - Romania 9
AU - Australia 8
AE - Emirati Arabi Uniti 6
HU - Ungheria 6
PH - Filippine 6
PT - Portogallo 6
RS - Serbia 6
CL - Cile 5
GR - Grecia 5
BD - Bangladesh 4
BH - Bahrain 4
LK - Sri Lanka 4
MA - Marocco 4
MT - Malta 4
PK - Pakistan 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
AR - Argentina 3
AZ - Azerbaigian 3
DK - Danimarca 3
DZ - Algeria 3
EC - Ecuador 3
IL - Israele 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PE - Perù 3
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
HR - Croazia 2
IQ - Iraq 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
ET - Etiopia 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
NP - Nepal 1
PA - Panama 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
UG - Uganda 1
Totale 14.377
Salva come PNG Salva come JPEG
Città #
Chandler 1.363
Singapore 471
Ashburn 439
Jacksonville 321
Dublin 310
San Mateo 260
Nanjing 199
Jakarta 188
Wilmington 181
Dearborn 165
Warsaw 144
Nürnberg 140
New York 135
Milan 132
Boston 124
Bremen 123
Woodbridge 115
Marseille 112
Ann Arbor 106
Beijing 100
Izmir 88
Lawrence 85
Cattolica 84
Helsinki 82
Rome 80
Houston 79
Princeton 79
Fairfield 76
Moscow 76
Nanchang 76
Munich 67
Seattle 57
Redwood City 56
Abidjan 53
Brussels 53
Los Angeles 49
Leawood 40
Zhengzhou 37
University Park 36
Shenyang 34
Toronto 34
Hebei 32
Kunming 32
Phoenixville 32
Augusta 29
Fremont 29
Boardman 28
Tianjin 28
Changsha 27
Jiaxing 26
Lancaster 26
Cambridge 25
Falls Church 25
Mountain View 25
Norwalk 23
Pune 22
Detroit 21
North York 21
Auburn Hills 20
Shanghai 20
Brno 19
Hangzhou 18
Redmond 18
Guangzhou 17
Frankfurt am Main 16
London 15
Chicago 14
Falkenstein 14
Hanoi 14
Lanzhou 13
Monmouth Junction 13
Washington 13
Vienna 12
Amsterdam 11
Nuremberg 11
Andover 10
Ardabil 10
Hong Kong 10
Ottawa 10
Edinburgh 9
San Francisco 9
Hefei 8
Phoenix 8
Sacramento 8
Bari 7
Berlin 7
Bologna 7
Cedar Knolls 7
Central District 7
Indiana 7
Jinan 7
Ningbo 7
Tokyo 7
Cairo 6
Chengdu 6
Mumbai 6
Sergii 6
Simi Valley 6
São Paulo 6
Costa Mesa 5
Totale 7.344
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 799
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 254
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 169
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 166
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 149
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 147
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 144
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 143
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 140
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 140
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 139
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 139
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 134
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 134
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 133
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 133
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 131
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 131
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 130
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 129
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 129
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 129
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 129
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 129
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 129
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 128
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 126
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 123
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 122
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 120
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 120
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 117
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 116
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 115
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 114
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 113
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 112
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 112
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 112
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 111
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 111
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 109
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 109
In Vivo Portal Dosimetry by an Ionization Chamber 108
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 107
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 105
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 103
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 103
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 102
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 102
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 101
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 101
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 100
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 100
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 100
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 100
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 98
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 98
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 97
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 97
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 95
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 95
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 95
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 93
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 92
Real time transit dosimetry for the breath-hold radiotherapy technique experience 89
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 89
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 89
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 89
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 89
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 87
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 86
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 86
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 85
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 85
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 84
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 83
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 83
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 83
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 83
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 80
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 78
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 78
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 77
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 77
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 76
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 76
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 76
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 75
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups 75
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 74
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 71
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 71
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 70
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 70
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 70
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 69
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 68
Totale 11.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.450
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020840 0 0 0 0 0 0 0 122 196 159 228 135
2020/20211.214 64 141 24 136 161 48 128 31 129 98 197 57
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20251.305 106 84 240 136 419 103 97 120 0 0 0 0
Totale 15.036